您当前的位置：
首页 >
文章列表页 >
Preclinical evaluation of osteogenic effects of 99Tc-MDP in osteoporosis models
NUCLEAR CHEMISTRY, RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE | 更新时间：2025-04-03
|

    • Preclinical evaluation of osteogenic effects of 99Tc-MDP in osteoporosis models

    • “In the field of osteoporosis treatment, researchers have validated that 99Tc MDP stimulates osteoblast activity and effectively inhibits the process of osteoporosis by constructing a rat model, providing a new treatment approach.”
    • NUCLEAR TECHNIQUES   Vol. 48, Issue 3, Article number: 030302(2025)

    • DOI：10.11889/j.0253-3219.2025.hjs.48.240124    

      CLC： TL99

    • Received：01 April 2024，

      Revised：23 July 2024，

      Published：15 March 2025

    移动端阅览

  • REN Shengnan,LI Linlin,ZHANG Yun,et al.Preclinical evaluation of osteogenic effects of 99Tc-MDP in osteoporosis models[J].NUCLEAR TECHNIQUES,2025,48(03):030302-030302. DOI： 10.11889/j.0253-3219.2025.hjs.48.240124. CSTR： 32193.14.hjs.CN31-1342/TL.2025.48.240124.

  •  
  •  

0

Views

10

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0